Macom Technology Solutions Holdings, Inc. (MTSI) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
Forensic Analysis · Semiconductors · as of Sep 24, 2026
Macom Technology Solutions Holdings, Inc. (MTSI)
A forensic read on Macom Technology Solutions Holdings, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Safe
Financial health
15.4
Distress distance
Clean
Earnings quality
3
Forensic signals
87.4
P / E (ttm)
-4.1%
ROE
$21.1B
Market cap
32.6%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence, going concern, valuation). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Macom Technology Solutions Holdings, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 15.4, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
5.6%
FY2025
Return on invested capital.Return on invested capital is 5.6% in the latest fiscal year and slipping across FY2021–FY2025 from 8% — well below the ~10% cost of capital we hold this sector to, and it has been across FY2023–FY2025, so reinvested dollars have not been earning their keep. The capital base behind it cannot be compared across FY2021–FY2025: short-term debt is tagged in one of those two fiscal years and not the other, and an untagged line enters this calculation as zero, so any change in the base would be a change in what the filer tagged.
+1.3%/yr
FY2022–FY2025
Share-count dilution.Diluted share count changed +4% over the last 3 years to FY2025 (+1.3%/yr). The count is growing: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~1.3% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2022 has been diluted ~4%.
+18.3%
FY2024→FY2025
Accruals ratio (% of NOA).Net operating assets grew +18.3% relative to their own average in FY2025 — scaled by NOA itself, not by total assets, which is what the Forensic Screens card's own accrual row divides by. Accruals are building faster than is comfortable — part of profit is sitting in the balance sheet rather than turning to cash. The build is led by receivables up +41% against revenue +33% and inventory up +22% against +31% in cost of sales. A cash-flow measure on the same base disagrees: reported earnings ran behind operating cash by 18% of net operating assets, against an accruals ratio of 18.3%. The two are computed differently: the accruals ratio is the change in net operating assets over average net operating assets, while the cash-flow figure is net income less operating cash flow over that same average. Read them as two results, not one.
Key fundamentals
Latest Revenue$967.3M
Revenue Growth YoY+32.6%
Revenue CAGR (3yr)+12.7%
Net Margin-5.6%
Free Cash Flow$192.8M
Return on Equity-4.1%
Debt / Equity0.38x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Macom Technology Solutions Holdings, Inc.'s actual 10-K/10-Q/8-K filings?